Loyola Researcher Jawed Fareed, PhD , Receives Lifetime Achievement Award

MAYWOOD, Ill. -- Loyola University Health System researcher Jawed Fareed, PhD, one of the world's leading experts on the causes and treatments of blood clots, has received the Lifetime Achievement Award from the Association of Practicing Pathologists in India. Fareed has written and contributed to several textbooks and is the author or co-author of more than 500 scientific articles on blood clots and vascular and cardiovascular disorders. His studies have been instrumental in the development of new blood-thinning and clot-busting drugs. Fareed has developed blood tests to detect the presence or formation of blood clots, which can cause strokes, heart attacks, pulmonary embolisms and deep vein thrombosis. He also has worked with interventional cardiologists to provide guidelines for the use of blood thinners in heart procedures. "He is a pioneer in the area of thrombosis and hemostasis," said Debra Hoppensteadt, technical director of Loyola's Hemostasis and Thrombosis Laboratories. (Thrombosis is the formation or presence of a blood clot; hemostasis is the stoppage of bleeding or hemorrhage.) Fareed received the Lifetime Achievement Award during a meeting of the practicing pathologists association in New Delhi. The award was given in recognition of Fareed's "extensive work . . . in the field of pathogenesis of thrombotic disorders and cardiovascular medicine." Fareed was born in Jaipur, Rajasthan, India, and did his graduate training in England, Canada and the United States. He has been at Loyola since earning a doctorate in 1976 from Loyola University Chicago Stritch School of Medicine. Fareed is the director of Loyola's Special Coagulation Laboratory and Hemostasis and Thrombosis Research Program. He is a professor in the departments of Pathology and Molecular Pharmacology and Therapeutics at Loyola's Stritch School of Medicine. Fareed has lectured worldwide and has received numerous awards from national and international organizations. He has been an advisor to the World Health Organization and several regulatory agencies, and is an elected fellow of the International Union of Angiology and the American College of Angiology. "He is a very well-rounded researcher who looks at a problem from multiple disciplines," said Jeanine Walenga, PhD, professor in the departments of Thoracic & Cardiovascular Surgery and Pathology. "He also is extremely hard-working. I don't know where he gets all his energy."